Twist Bioscience: Writing the Future of Synthetic Biology
Mar 8th, 2022, 3:30 - 4:30pm Virtual event
Parse Biosciences Raises $41.5M Series B Round to Scale Single-Cell Sequencing Products and Expand Product Portfolio
Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series B funding co-led by Marshall Wace and Janus Henderson Investors. Soleus Capital, Logos Capital…
Microfluidic Cell Sorting to Improve Genomic Sample Prep and Cell Cloning Results
Feb 17th, 2022, 10:30 - 12:00pm Virtual event
Mission Bio transfers 1st Tapestri GMP-ready CGT assay
Mission Bio has completed the first tech transfer of a clinical trial-, good manufacturing practices (GMP)-ready cell and gene therapy (CGT) assay from its Tapestri platform to Avance Biosciences, to…